viernes, 1 de diciembre de 2017

Genetics of Skin Cancer (PDQ®)—Health Professional Version - National Cancer Institute

Genetics of Skin Cancer (PDQ®)—Health Professional Version - National Cancer Institute



National Cancer Institute

Genetics of Skin Cancer (PDQ®)–Health Professional Version





SECTIONS





Changes to This Summary (11/22/2017)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Revised text to state that once basal cell carcinoma is detected, the National Comprehensive Cancer Network (NCCN) recommends complete skin examinations every 6 to 12 months for the first 5 years, and then at least annually for life (added NCCN as reference 130).
Added NCCN as reference 121.
Revised text to state that Spanish and Italian case-control studies found odds ratios of approximately 3.0 for melanoma in carriers of the MITFE318K variant (cited Ghiorzo et al. as reference 167). Also added text to state that the MITF E318K variant may be associated with nodular melanoma, as 5 of 12 carriers in the Italian study had nodular melanoma compared with only 90 of 655 melanoma patients not carrying the variant.
This summary is written and maintained by the PDQ Cancer Genetics Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
  • Updated: November 22, 2017

1 comentario: